Immunome Inc (IMNM)
7.89 x 1 7.93 x 1
Post-market by (Cboe BZX)
7.91 +0.74 (+10.32%) 04/17/25 [NASDAQ]
7.89 x 1 7.93 x 1
Post-market 7.90 -0.01 (-0.13%) 17:29 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select FieldsSymbol | IMNM | DAWN | PRAX | ||
Company | Immunome Inc | Day One Biopharmaceuticals Inc | Praxis Precision Medicines Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 7.13 | 6.69 | 29.78 | ||
High | 7.96 | 6.88 | 34.00 | ||
Low | 6.97 | 6.63 | 29.47 | ||
Last | 7.91 | 6.84 | 33.79 | ||
Change | +0.74 | +0.08 | +3.97 | ||
% Change | +10.32% | +1.18% | +13.29% | ||
Volume | 1,494,000 | 1,189,200 | 450,900 | ||
20-Day Average Volume | 1,712,675 | 1,102,555 | 570,220 | ||
Previous Close | 7.17 | 6.76 | 29.83 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 6.86 | 7.53 | 33.77 | ||
20-Day Raw Stochastic | 76.88% | 21.18% | 54.96% | ||
20-Day Relative Strength | 50.56% | 36.30% | 40.09% | ||
Weighted Alpha | -57.83 | -57.05 | -7.16 | ||
Today's Opinion | 88% Sell | 100% Sell | 72% Sell | ||
Previous Opinion | 88% Sell | 100% Sell | 88% Sell | ||
Last Month's Opinion | 100% Sell | 100% Sell | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +27.58% since 04/10/25 | +1.18% since 04/10/25 | +18.69% since 04/10/25 | ||
Low | 6.09 on 04/11/25 | 6.60 on 04/11/25 | 28.12 on 04/11/25 | ||
High | 7.96 on 04/17/25 | 7.42 on 04/15/25 | 34.00 on 04/17/25 | ||
1-Month | |||||
%Chg | -12.50% since 03/17/25 | -21.11% since 03/17/25 | -13.20% since 03/17/25 | ||
Low | 5.15 on 04/09/25 | 6.41 on 04/09/25 | 26.70 on 04/09/25 | ||
High | 8.95 on 03/18/25 | 8.65 on 03/18/25 | 39.60 on 03/28/25 | ||
3-Month | |||||
%Chg | -20.82% since 01/17/25 | -45.45% since 01/17/25 | -52.10% since 01/17/25 | ||
Low | 5.15 on 04/09/25 | 6.41 on 04/09/25 | 26.70 on 04/09/25 | ||
High | 12.44 on 02/10/25 | 13.53 on 01/28/25 | 91.83 on 02/14/25 | ||
6-Month | |||||
%Chg | -34.57% since 10/17/24 | -54.64% since 10/17/24 | -54.90% since 10/17/24 | ||
Low | 5.15 on 04/09/25 | 6.41 on 04/09/25 | 26.70 on 04/09/25 | ||
High | 15.13 on 12/09/24 | 16.76 on 11/08/24 | 91.83 on 02/14/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 687,782 | 693,261 | 681,308 | ||
Shares Outstanding, K | 86,951 | 101,354 | 20,163 | ||
Annual Sales | 9,040,000 | 131,160,000 | 8,550,000 | ||
Annual Net Income | -292,960,000 | -95,500,000 | -182,820,000 | ||
Last Quarter Sales | 2,740,000 | 29,210,000 | 7,460,000 | ||
Last Quarter Net Income | -80,250,000 | -65,710,000 | -58,680,000 | ||
60-Month Beta | 2.05 | -1.24 | 2.66 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.84 on 03/19/25 | -0.69 on 02/25/25 | -2.94 on 02/28/25 | ||
Latest Earnings Date | 05/13/25 | 05/05/25 | 05/12/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |